Business
Vortex Announces Liquid Biopsy Study in NPJ
Vortex Announces Liquid Biopsy Study in NPJ.
About this update from Emv Capital Plc
[{"type":"text","content":"\n \nRNS Number : 2547V NetScientific PLC 01 November 2017 \n\nNetScientific plc\n(\"NetScientific\" or the \"Company\" or the \"Group\")\n \n \nVortex Biosciences Announces Publication of Liquid Biopsy Study in Nature Partner Journals Genomic Medicine\n \nLondon, UK - 1 November 2017 - NetScientific plc (\"NetScientific\", AIM:NSCI), the transatlantic healthcare IP commercialisation group, announces an update from its portfolio company, Vortex BioSciences, which today announced the publication of \"Workflow optimization of whole genome amplification and targeted panel sequencing for CTC mutation detection\" in Nature Partner Journals (npj) Genomic Medicine on 1 November 2017. Source: https://tinyurl.com/ybhuzpu4 DOI Number: 10.1038/s41525-017-0034-3\nThe peer-reviewed publication describes the use of Vortex's technology to capture and examine circulating tumor cells (CTCs) from patients with colorectal cancer. Vortex's technology allows for an optimised workflow for performing whole genome amplification (WGA) and targeted next-generation sequencing (NGS) on these captured CTCs. The study was completed in collaboration with Professor Stefanie Jeffrey, Chief of Surgical Oncology Research at Stanford University School of Medicine. \nCommenting on the news, Francois Martelet, Chairman of Vortex BioSciences Inc. and CEO of NetScientific said: \"We are pleased to see the publication of high-impact research in the field of liquid biopsy involving Vortex's VTX-1 platform, which we believe can give researchers the opportunity to open new windows into understanding cancer. This research marks an important step point in the commercialisation journey for Vortex, with the paper demonstrating the ability for CTCs collected by the VTX-1 machine to understand cancer progression, enabling disease identification and monitoring.\"\n \n \n# # #\n \nFor more information, please contact:\n \n\n\n\n\n NetScientific\n François R. Martelet, M.D., CEO\n Ian Postlethwaite, CFO\n\n\nTel: +44 (0)20 3514 1800\n\n\n\n\n \n Consilium Strategic Communications\n Mary-Jane Elliott / Jessica Hodgson /\n Chris Welsh / Laura Thornton \n\n\n \nTel: +44 (0)20 3709 5700\[email protected]\n\n\n\n\nStifel Nicolaus Europe Limited (NOMAD and Broke...